Interventional technology firm Medtronic reported that it has completed patient enrollment in its Endeavor IV clinical study, a step toward final data evaluation of the drug-eluting coronary stent system and submission of an application to the U.S. Food and Drug Administration for possible approval.
In other stent-trial news, the Minneapolis-based firm said it has completed enrollment in two other clinical trials: its Resolute study evaluating the company's next-generation drug-eluting stent product, and the Endeavor-Japan study, evaluating the stent at 12 clinical sites in that country.
By AuntMinnie.com staff writers
June 28, 2006
Related Reading
Medtronic to bring Endeavor to China, June 21, 2006
Medtronic nets French reimbursement approval, June 12, 2006
Stereotaxis, Medtronic partner for clinical study, May 18, 2006
Medtronic gets nod for Micro-Driver, May 1, 2006
Medtronic sues Kyphon, April 17, 2006
Copyright © 2006 AuntMinnie.com
